Abstract
The cytochrome P450 (P450, CYP) are the superfamily of heme-containing monooxygenase enzymes, found throughout all nature including mammals, plants, and microorganisms. Mammalian P450 enzymes are involved in oxidative metabolism of a wide range of endo- and exogenous chemicals. Especially P450s involved in drug metabolisms are important for drug efficacy and polymorphisms of P450s in individuals reflect differences of drug responses between people. To study the functional differences of CYP2A6, CYP2D6, and CYP4A11 variants, we cloned the four CYP2A6, three CYP2D6, and three CYP4A11 variants, which were found in Korean populations, in mammalian expression vector pcDNA by PCR and examined their expressions in COS-7 mammalian cells using immunoblots using P450 specific polyclonal antibodies. Three of four CYP2A6, two of three CYP4A11, and two of three CYP2D6 variants showed expressions in COS-7 cells but the relative levels of expressions are remarkably different in those of each variants. Our findings may help to study and explain the differences between functions of CYP variants and drug responses in Korean populations.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bandiera, S., Weidlich, S., Harth, V., Broede, P., Ko, Y. and Friedberg, T. (2005). Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-transla-tional regulation of CYP1B1 expression. Mol Pharmacol, 67, 435–443.
Cho, B.H., Park, B.L., Kim, L.H., Chung, H.S. and Shin, H.D. (2005). Highly polymorphic human CYP4A11 gene. J. Hum. Genet, 50, 259–263.
Daly, A.K. (1995). Molecular basis of polymorphic drug metabolism. J. Mol Med., 73, 539–553.
Danielson, P.B. (2002). The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr. Drug. Metab., 3, 561–597.
Di, Y.M., Chow, V.D., Yang, L.P. and Zhou, S.F. (2009). Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr. Drug. Metab., 10, 754–780.
Elbekai, R.H. and El-Kadi, A.O. (2006). Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol. Ther, 112, 564–587.
Fernandez-Salguero, P., Hoffman, S.M., Cholerton, S., Mohrenweiser, H., Raunio, H., Rautio, A., Pelkonen, O., Huang, I.D., Evans, W.E., Idle, J.R. and Gonzalez, F.J. (1995). A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet., 57, 651–660.
Gainer, J.V., Bellamine, A., Dawson, E.P., Womble, K.E., Grant, S.W., Wang, Y., Cupples, L.A., Guo, C.Y., Demissie, S., O’Donnell, C.J., Brown, N.J., Waterman, M.R. and Capdevila, J.H. (2005). Functional variant of CYP4A11 20-hydroxyeico-satetraenoic acid synthase is associated with essential hypertension. Circulation, 111, 63–69.
Gardiner, S.J. and Begg, E.J. (2006). Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev., 58, 521–590.
Guengerich, F.P. (2008). Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol, 21, 70–83.
Ingelman-Sundberg, M., Sim, S.C., Gomez, A. and Rodriguez-Antona, C. (2007). Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepige-netic and clinical aspects. Pharmacol Ther, 116, 496–526.
Jansson, I., Stoilov, I., Sarfarazi, M. and Schenkman, J.B. (2001). Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism. Pharmacogenetics, 11, 793–801.
Kwon, I.T., Nakajima, M., Chai, S., Yom, Y.K., Kim, H.K., Yamazaki, H., Sohn, D.R., Yamamoto, T., Kuroiwa, Y. and Yokoi, T. (2001). Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics, 11, 317–323.
Lasker, J.M., Chen, W.B., Wolf, I., Bloswick, B.P., Wilson, P.D. and Powell, P.K. (2000). Formation of 20-hydroxyeicosatet-raenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4All. J. Biol. Chem., 275, 4118–4126.
Lee, S.J., Lee, S.S., Jung, H.I., Kim, H.S., Park, S.J., Yeo, C.W. and Shin, J.G (2009). Discovery of novel functional variants and extensive evaluation of C YP2D6 genetic polymorphisms in Koreans. Drug. Metab. Dispos., 37, 1464–1470.
McFadyen, M.C., Melvin, W.T. and Murray, G.I. (2004). Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol. Cancer. Ther, 3, 363–371.
Nakajima, M., Fukami, T., Yamanaka, H., Higashi, E., Sakai, H., Yoshida, R., Kwon, I.T., McLeod, H.L. and Yokoi, T. (2006). Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin. Pharmacol Ther, 80, 282–297.
Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M. and Nebert, D.W. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudo-genes and alternative-splice variants. Pharmacogenetics, 14, 1–18.
Owen, R.P., Sangkuhl, K., Klein, T.E. and Airman, R.B. (2009). Cytochrome P450 2D6. Pharmacogenet Genomics, 19, 559–562.
Rodriguez-Antona, C. and Ingelman-Sundberg, M. (2006). Cytochrome P450 pharmacogenetics and cancer. Oncogene, 25, 1679–1691.
van Schaik, R.H. (2005). Cancer treatment and pharmacogenetics of cytochrome P450 enzymes. Invest New Drugs, 23, 513–522.
Wrighton, S.A. and Stevens, J.C. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol, 22, 1–21.
Zanger, U.M., Raimundo, S. and Eichelbaum, M. (2004). Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch. Pharmacol, 369, 23–37.
Zordoky, B.N. and El-Kadi, A.O. (2010). Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther, 125, 446–463.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lee, H.J., Park, M.K., Park, Y.R. et al. Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line. Toxicol Res. 27, 25–29 (2011). https://doi.org/10.5487/TR.2011.27.1.025
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2011.27.1.025